Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Chinese Patent Office
Express Scripts
Fish and Richardson
Moodys
AstraZeneca
Deloitte
Colorcon
Julphar

Generated: August 20, 2017

DrugPatentWatch Database Preview

FLUNISOLIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Flunisolide, and when can generic versions of Flunisolide launch?

Flunisolide is a drug marketed by Hi Tech Pharma Co, Bausch And Lomb, and Apotex Inc. and is included in three NDAs.

The generic ingredient in FLUNISOLIDE is flunisolide. There are twelve drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the flunisolide profile page.

Summary for Tradename: FLUNISOLIDE

Patents:0
Applicants:3
NDAs:3
Suppliers / Packagers: see list3
Bulk Api Vendors: see list26
Clinical Trials: see list4
Patent Applications: see list6,566
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FLUNISOLIDE at DailyMed

Pharmacology for Tradename: FLUNISOLIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hi Tech Pharma Co
FLUNISOLIDE
flunisolide
SPRAY, METERED;NASAL077704-001Aug 3, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Bausch And Lomb
FLUNISOLIDE
flunisolide
SPRAY, METERED;NASAL074805-001Feb 20, 2002ABRXNoYes► Subscribe► Subscribe► Subscribe
Apotex Inc
FLUNISOLIDE
flunisolide
SPRAY, METERED;NASAL077436-001Aug 9, 2007RXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Chinese Patent Office
US Army
Fish and Richardson
Boehringer Ingelheim
Baxter
Harvard Business School
Argus Health
Cipla
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot